Register
Login:
Share:
Email Facebook Twitter

Josh Mahony from IG sums up the forces driving markets and currencies Watch here

Leading commentator Josh Mahony from IG - are we seeing a US$ revaluation?


Summit Ther Share Price (SUMM)



Share Price Information for Summit Ther (SUMM)


Share Price: 195.00Bid: 190.00Ask: 200.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 10.00Spread as %: 5.26%Open: 195.00High: 195.00Low: 190.00Yesterday’s Close: 195.00

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
195.00

Share Price SpacerBid
190.00

Share Price SpacerAsk
200.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
3,257

Share Price SpacerOpen
195.00

Share Price SpacerHigh
195.00

Share Price SpacerLow
190.00

Share Price SpacerClose
195.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 61.93m £120.76m 1,500

52 Week High 260.00 52 Week High Date 4-OCT-2016
52 Week Low 90.00 52 Week Low Date 16-SEP-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
5 2,907 0 -5.571 -35.00 0.00 0.00


London South East Users info for Summit Ther




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

18-Aug-17
13:58:34
190.00
1,500
Sell* 
190.00
200.00
2,850
Trade Type:
Ordinary

18-Aug-17
12:15:33
190.00
1,400
Sell* 
190.00
200.00
2,660
Trade Type:
Ordinary

18-Aug-17
10:48:06
194.00
7
Sell* 
190.00
200.00
13.58
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
18-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
David Wurzer held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 David Wurzer
2.33USD7,5007500
17-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
Valerie Andrews held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Valerie Andrews
2.3USD10,50010500
16-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
2.34USD4,25014442
View more Summit Ther directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 00:11OlliehRE: And mellon195.00Hold
End of 2014 .....Galloway, a firm which is owned by a Trust of which Mellon is a life tenant, holds 5.95% of Summit.
Sun 20:00AppleMacManRE: And mellon195.00No Opinion
What is Mellon's current holding?
Sat 06:41lizardkingRE: And mellon195.00No Opinion
Maybe he was too busy as he had plans to set up a few aim companies!!! If he had done nothing then he would be lying surely.
Sat 00:39Thoth2And mellon195.00No Opinion
Bit of showbiz for the punters.
Too busy and resigned. Set up a few aim companies since resigning. Too busy for summ ? Wolves and sheep. Why woyld he lie about reasons for leaving ?
Sat 00:30Thoth2Elephants forgetting195.00No Opinion
The lucences to Taiwan. No updates
The licence to tb initiave. No update.
Armstrong 2012. No fundraise. Then did.
Uptrophyn. Does it work in humans. ? And if so does it switch off after a few years ? It does in infancy. How and why we dont know yet
Sarepta. Are we the golden shot ? Or the program that gets investment pulled in the portfolio. ? Not expecting a rational outcome. C diff. Chase it. No one is buying antibiotics so its a fundraise if succesful. Gla.… Read More
Thu 12:28AppleMacManFID v RID schedule?195.00No Opinion
Does anyone know where we're up to with re - schedule for FID versus RID results? Thanks AMM

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Summit Ther (SUMM) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.